Clinical implement of Probe-Capture Metagenomics in sepsis patients: A multicentre and prospective study

Abstract

Background: Accurate pathogen identification is critical for managing sepsis. However, traditional microbiological methods are time-consuming and exhibit limited sensitivity, particularly with blood samples. Metagenomic sequencing of plasma or whole blood was highly affected by the proportion of host nucleic acid.

Methods: We developed a Probe-Capture Metagenomic assay and established a multicentre prospective cohort to assess its clinical utility. In this study, 184 blood samples from patients suspected of sepsis were sent for blood culture and Probe-Capture Metagenomic sequencing before using antibiotics. The pathogen-positive rate and auxiliary abilities in diagnosis were compared among Probe-Capture Metagenomics, blood culture and real-time PCR (RT-PCR). Antibiotic therapy adjustments were based on the identification of pathogens, and changes in the Sequential Organ Failure Assessment (SOFA) score were monitored on days 0, 3 and 7 of admission.

Results: A total of 184 sepsis patients were enrolled, with a mean age of 66 years (range 56–74). The Probe-Capture Metagenomics method, confirmed by RT-PCR, demonstrated a significantly higher pathogen detection rate than blood culture alone (51.6% vs. 17.4%, p < .001). When combining the results of blood culture and RT-PCR, Probe-Capture Metagenomics achieved a concordance rate of 91.8% (169/184), with a sensitivity of 100% and specificity of 87.1%. In terms of clinical impact, antibiotic therapy was adjusted for 64 patients (34.8%) based on the results from Probe-Capture Metagenomics, and 41 patients (22.3%) showed a > 2-point decrease in SOFA score following antibiotic adjustments.

Conclusion: Probe-Capture Metagenomics significantly enhances the ability of pathogen detection compared with traditional metagenomics. Compared to blood culture and RT-PCR in sepsis patients, it leads to improved antibiotic treatment and better patient outcomes. This study, for the first time, evaluates the clinical impact of metagenomic sequencing by integrating antibiotic adjustments and SOFA score changes, indicating that approximately one-fifth of sepsis patients benefit from this advanced diagnostic approach.

Trial registration: This study has been registered in clinical trials (clinicaltrials.gov) on 30 November 2018, and the registration number is NCT03760315.

Keywords

antibiotics adjustment / clinical impact / diagnosis / metagenomics / sepsis

References

[1] Kheterpal S, Singh K, Topol EJ. Digitising the prediction and management of sepsis. Lancet. 2022; 399(10334): 1459.

[2] Bloos F, Rüddel H, Thomas-Rüddel D, et al. Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med. 2017; 43(11): 1602-1612.

[3] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47(11): 1181-1247.

[4] Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021; 21(2): 241-251.

[5] Rhee C, Kadri SS, Dekker JP, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020; 3(4): e202899.

[6] Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. 2007; 30(Suppl 1): S7-15.

[7] Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med. 2012; 40(12): 3277-3282.

[8] Peri AM, Harris PNA, Paterson DL. Culture-independent detection systems for bloodstream infection. Clin Microbiol Infect. 2022; 28(2): 195-201.

[9] Jing C, Chen H, Liang Y, et al. Clinical evaluation of an improved metagenomic next-generation sequencing test for the diagnosis of bloodstream infections. Clin Chem. 2021; 67(8): 1133-1143.

[10] Qin C, Zhang S, Zhao Y, Ding X, Yang F, Zhao Y. Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection. Front Cell Infect Microbiol. 2023; 13: 1117987.

[11] Yan G, Liu J, Chen W, et al. Metagenomic next-generation sequencing of bloodstream microbial cell-free nucleic acid in children with suspected sepsis in pediatric intensive care unit. Front Cell Infect Microbiol. 2021; 11: 665226.

[12] Ren D, Ren C, Yao R, et al. The microbiological diagnostic performance of metagenomic next-generation sequencing in patients with sepsis. BMC Infect Dis. 2021; 21(1): 1257.

[13] Chien JY, Yu CJ, Hsueh PR. Utility of metagenomic next-generation sequencing for etiological diagnosis of patients with sepsis in intensive care units. Microbiol Spectr. 2022; 10(4): e0074622.

[14] Sun L, Zhang S, Yang Z, et al. Clinical application and influencing factor analysis of metagenomic next-generation sequencing (mNGS) in ICU patients with sepsis. Front Cell Infect Microbiol. 2022; 12: 905132.

[15] Yin M, Zheng Y, Zhang L, et al. The real-life performance of metagenomic next-generation sequencing in sepsis. J Infect. 2022; 84(3): 418-467.

[16] Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019; 14: 319-338.

[17] Ebinger A, Fischer S, Höper D. A theoretical and generalized approach for the assessment of the sample-specific limit of detection for clinical metagenomics. Comput Struct Biotechnol J. 2021; 19: 732-742.

[18] Allicock OM, Guo C, Uhlemann AC, et al. BacCapSeq: a platform for diagnosis and characterization of bacterial infections. mBio. 2018; 9(5): e02007-18.

[19] Liu X, Gan Z, Lin Z, et al. Exploring the value of hybrid capture-based next-generation sequencing technology in the suspected diagnosis of bloodstream infections. PeerJ. 2024; 12: e18471.

[20] Dickson ZW, Hackenberger D, Kuch M, et al. Probe design for simultaneous, targeted capture of diverse metagenomic targets. Cell Rep Methods. 2021; 1(6): 100069.

[21] Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7): 707-710.

[22] Arakawa M, Levy JH, Fujimori K, Kondo K, Iba T. A new SOFA score calculation to improve the predictive performance for mortality in sepsis-associated disseminated intravascular coagulopathy patients. J Crit Care. 2021; 64: 108-113.

[23] Moreno R, Rhodes A, Piquilloud L, et al. The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update? Crit Care. 2023; 27(1): 15.

[24] de Grooth H-J, Geenen IL, Girbes AR, Vincent J-L, Parienti J-J, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017; 21(1): 38.

[25] Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017; 317(3): 290-300.

[26] Schertz AR, Lenoir KM, Bertoni AG, Levine BJ, Mongraw-Chaffin M, Thomas KW. Sepsis prediction model for determining sepsis vs SIRS, qSOFA, and SOFA. JAMA Netw Open. 2023; 6(8): e2329729.

[27] Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8): 801-810.

[28] Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001; 286(14): 1754-1758.

[29] Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10): 818-829.

[30] Pedulla ML, Ford ME, Houtz JM, et al. Origins of highly mosaic mycobacteriophage genomes. Cell. 2003; 113(2): 171-182.

[31] Amar Y, Lagkouvardos I, Silva RL, et al. Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA. Microbiome. 2021; 9(1): 123.

[32] Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020; 27(6): 883-890 e2.

[33] Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15): 2114-2120.

[34] Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018; 34(17): i884-i890.

[35] Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14): 1754-1760.

[36] Miller S, Naccache SN, Samayoa E, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 2019; 29(5): 831-842.

[37] Grundy BS, Parikh H, Jacob S, et al. Pathogen detection using metagenomic next-generation sequencing of plasma samples from patients with sepsis in Uganda. Microbiol Spectr. 2023; 11(1): e0431222.

[38] Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med. 2021; 27(1): 115-124.

[39] Picelli S, Björklund AK, Reinius B, Sagasser S, Winberg G, Sandberg R. Tn5 transposase and tagmentation procedures for massively scaled sequencing projects. Genome Res. 2014; 24(12): 2033-2040.

[40] Diao Z, Lai H, Han D, Yang B, Zhang R, Li J. Validation of a metagenomic next-generation sequencing assay for lower respiratory pathogen detection. Microbiol Spectr. 2023; 11(1): e0381222.

[41] Marotz CA, Sanders JG, Zuniga C, Zaramela LS, Knight R, Zengler K. Improving saliva shotgun metagenomics by chemical host DNA depletion. Microbiome. 2018; 6(1): 42.

[42] Bal A, Pichon M, Picard C, et al. Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow. BMC Infect Dis. 2018; 18(1): 537.

[43] Prachayangprecha S, Schapendonk CM, Koopmans MP, et al. Exploring the potential of next-generation sequencing in detection of respiratory viruses. J Clin Microbiol. 2014; 52(10): 3722-3730.

[44] Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019; 4(4): 663-674.

[45] Wu J, Tang B, Qiu Y, et al. Clinical validation of a multiplex droplet digital PCR for diagnosing suspected bloodstream infections in ICU practice: a promising diagnostic tool. Crit Care. 2022; 26(1): 243.

[46] Bunse T, Ziel A, Hagen P, et al. Analytical and clinical evaluation of a novel real-time PCR-based detection kit for Mpox virus. Med Microbiol Immunol. 2024; 213(1): 18.

[47] Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2): 165-228.

[48] Burillo A, Bouza E. Use of rapid diagnostic techniques in ICU patients with infections. BMC Infect Dis. 2014; 14: 593.

[49] Han D, Li Z, Li R, Tan P, Zhang R, Li J. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019; 45(5-6): 668-685.

[50] Ramachandran PS, Ramesh A, Creswell FV, et al. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics. Nat Commun. 2022; 13(1): 1675.

[51] Yang MA, Fan X, Sun B, et al. Ancient DNA indicates human population shifts and admixture in northern and southern China. Science. 2020; 369(6501): 282-288.

[52] Wu X, Shi Q, Shen S, Huang C, Wu H. Clinical and bacterial characteristics of Klebsiella pneumoniae affecting 30-day mortality in patients with bloodstream infection. Front Cell Infect Microbiol. 2021; 11: 688989.

[53] Li X, Liang S, Zhang D, He M, Zhang H. The clinical application of metagenomic next-generation sequencing in sepsis of immunocompromised patients. Front Cell Infect Microbiol. 2023; 13: 1170687.

[54] Shishido AA, Noe M, Saharia K, Luethy P. Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study. BMC Infect Dis. 2022; 22(1): 372.

[55] Lyu QQ, Zheng RQ, Chen QH, Yu JQ, Shao J, Gu XH. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial. Crit Care. 2022; 26(1): 295.

[56] Lee RA, Al Dhaheri F, Pollock NR, Sharma TS. Assessment of the clinical utility of plasma metagenomic next-generation sequencing in a pediatric hospital population. J Clin Microbiol. 2020; 58(7): e00419-20.

[57] Xu C, Chen X, Zhu G, et al. Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders. J Infect. 2023; 86(1): 14-23.

[58] de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017; 21(1): 38.

[59] Karakike E, Kyriazopoulou E, Tsangaris I, Routsi C, Vincent JL, Giamarellos-Bourboulis EJ. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care. 2019; 23(1): 387.

[60] Laterre PF, Pickkers P, Marx G, et al. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med. 2021; 47(11): 1284-1294.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.